{"id":"stn1013800-ophthalmic-solution","safety":{"commonSideEffects":[{"rate":"null","effect":"Increased intraocular pressure"}]},"_chembl":{"chemblId":"CHEMBL2108251","moleculeType":"Oligosaccharide"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by suppressing the immune system's response to reduce inflammation and swelling in the eye. This can help to alleviate symptoms associated with conditions such as uveitis and other inflammatory eye diseases.","oneSentence":"STN1013800 ophthalmic solution is a corticosteroid used to treat inflammation in the eye.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:36:34.274Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of non-infectious uveitis affecting the posterior segment of the eye"}]},"trialDetails":[{"nctId":"NCT06911216","phase":"EARLY_PHASE1","title":"A Pharmacokinetics (PK) Study in Healthy Adults","status":"COMPLETED","sponsor":"Santen Pharmaceutical Co., Ltd.","startDate":"2025-03-17","conditions":"Blepharoptosis","enrollment":8},{"nctId":"NCT06514612","phase":"PHASE3","title":"LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of Acquired Blepharoptosis.","status":"RECRUITING","sponsor":"Santen SAS","startDate":"2024-12-30","conditions":"Acquired Blepharophimosis","enrollment":234},{"nctId":"NCT06683651","phase":"PHASE3","title":"A Study in Chinese Patients With Acquired Blepharoptosis","status":"RECRUITING","sponsor":"Santen Pharmaceutical Co., Ltd.","startDate":"2024-10-22","conditions":"Blepharoptosis","enrollment":180}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1907,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"STN1013800 ophthalmic solution","genericName":"STN1013800 ophthalmic solution","companyName":"Santen Pharmaceutical Co., Ltd.","companyId":"santen-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"STN1013800 ophthalmic solution is a corticosteroid used to treat inflammation in the eye. Used for Treatment of non-infectious uveitis affecting the posterior segment of the eye.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}